CVE-2022-20698

Public Exploit
Clam AntiVirus (ClamAV) Denial of Service Vulnerability

Description

A vulnerability in the OOXML parsing module in Clam AntiVirus (ClamAV) Software version 0.104.1 and LTS version 0.103.4 and prior versions could allow an unauthenticated, remote attacker to cause a denial of service condition on an affected device. The vulnerability is due to improper checks that may result in an invalid pointer read. An attacker could exploit this vulnerability by sending a crafted OOXML file to an affected device. An exploit could allow the attacker to cause the ClamAV scanning process to crash, resulting in a denial of service condition.

Categories

7.5
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.27%
Vendor Advisory clamav.net Vendor Advisory gentoo.org
Affected: Cisco ClamAV
Affected: Cisco ClamAV
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2022-20698?
CVE-2022-20698 has been scored as a high severity vulnerability.
How to fix CVE-2022-20698?
To fix CVE-2022-20698, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-20698 being actively exploited in the wild?
It is possible that CVE-2022-20698 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-20698?
CVE-2022-20698 affects Cisco ClamAV, Cisco ClamAV.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.